Tazarotene
Tazarotene
Definition
A synthetic, topical retinoid. Tazarotene induces the expression of tazarotene-induced gene 3 (TIG3), a tumor suppressor gene. In psoriasis, tazarotene normalizes abnormal keratinocyte differentiation and reduces their hyperproliferation. (NCI04)
Also known as 6-[(3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]- 3-Pyridinecarboxylic Acid, Ethyl Ester, AGN-190168, Avage, Ethyl 6-(2-(4,4-Dimethylthiochroman-6-yl)ethynyl)nicotinate, TAZAROTENE, Tazorac — per NCIT
Also identified as
- ATC D05AX05 per RXNORM
- NCIT NCIT:C29487 per NCIT
- SCTID 108906007 per RXNORM
- SCTID 386935009 per RXNORM
- UNII 81BDR9Y8PS per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| Psoriasis | may treat | MEDRT · Public domain (U.S. Government work) |
Organ Effects
| Organ | Side effect / interaction | Source |
|---|---|---|
| Skin of body | may treat a disease of this organ | DERIVED · CC BY 4.0 |
1 entry above is marked DERIVED: Atlas Médico inferred it by combining two sourced claims, and no source asserts this link directly. Treat it as a navigation aid, not as a clinical statement.